A diagnostic dilemma: drug-induced aseptic meningitis in a 45-year-old HIV-positive man.
dc.contributor.author | Rowley, D | |
dc.contributor.author | Houlihan, L | |
dc.contributor.author | McFaul, K | |
dc.contributor.author | Clarke, S | |
dc.contributor.author | Lyons, F | |
dc.date.accessioned | 2014-07-25T08:47:16Z | |
dc.date.available | 2014-07-25T08:47:16Z | |
dc.date.issued | 2014-03 | |
dc.identifier.citation | Rowley D et al. A diagnostic dilemma: drug-induced aseptic meningitis in a 45-year-old HIV-positive man. Int J STD AIDS 2014, 25 (4):309-11 | en_GB |
dc.identifier.issn | 1758-1052 | |
dc.identifier.pmid | 23999938 | |
dc.identifier.doi | 10.1177/0956462413501157 | |
dc.identifier.uri | http://hdl.handle.net/10147/323804 | |
dc.description.abstract | We describe a case of aseptic meningitis following the administration of moxifloxacin in a 45-year-old man with human immunodeficiency virus (HIV). At presentation he was receiving tuberculosis treatment on a modified regimen following severe hepatotoxicity; this included moxifloxacin, started 8 days previously. Initial cerebrospinal fluid (CSF) analysis was grossly abnormal. Anti-viral and -bacterial treatments were started. All microbiological tests proved negative and his moxifloxacin was withheld resulting in a complete normalisation of CSF. Drug-induced aseptic meningitis is a diagnosis of exclusion and presents a serious diagnostic dilemma. The decision to withhold medication cannot be taken lightly. | |
dc.language.iso | en | en |
dc.rights | Archived with thanks to International journal of STD & AIDS | en_GB |
dc.subject | HIV INFECTION | en_GB |
dc.subject | MENINGITIS | en_GB |
dc.subject.mesh | Anti-Bacterial Agents | |
dc.subject.mesh | Aza Compounds | |
dc.subject.mesh | HIV Infections | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Male | |
dc.subject.mesh | Meningitis, Aseptic | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Quinolines | |
dc.subject.mesh | Treatment Outcome | |
dc.title | A diagnostic dilemma: drug-induced aseptic meningitis in a 45-year-old HIV-positive man. | en_GB |
dc.type | Article | en |
dc.contributor.department | The GUIDE Clinic (Genitourinary and Infectious Disease Department), St James Hospital, Dublin, Ireland. | en_GB |
dc.identifier.journal | International journal of STD & AIDS | en_GB |
dc.description.funding | No funding | en |
dc.description.province | Leinster | en |
dc.description.peer-review | peer-review | en |
html.description.abstract | We describe a case of aseptic meningitis following the administration of moxifloxacin in a 45-year-old man with human immunodeficiency virus (HIV). At presentation he was receiving tuberculosis treatment on a modified regimen following severe hepatotoxicity; this included moxifloxacin, started 8 days previously. Initial cerebrospinal fluid (CSF) analysis was grossly abnormal. Anti-viral and -bacterial treatments were started. All microbiological tests proved negative and his moxifloxacin was withheld resulting in a complete normalisation of CSF. Drug-induced aseptic meningitis is a diagnosis of exclusion and presents a serious diagnostic dilemma. The decision to withhold medication cannot be taken lightly. |